Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
Conditions
Interventions
IDP-126 Gel
IDP-126 Component A
+3 more
Locations
34
United States
Valeant Site 02
Hot Springs, Arkansas, United States
Valeant Site 07
Fremont, California, United States
Valeant Site 08
Sacramento, California, United States
Valeant Site 09
Denver, Colorado, United States
Valeant Site 11
Boynton Beach, Florida, United States
Valeant Site 13
North Miami Beach, Florida, United States
Start Date
October 5, 2017
Primary Completion Date
April 23, 2019
Completion Date
April 23, 2019
Last Updated
November 10, 2021
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Bausch Health Americas, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions